This article is more than 5 years old. Information may no longer be current.

VIDEO: Rational strategy necessary for clinical follow-up in melanoma

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

NEW YORK — Merrick I. Ross, MD, professor in the department of surgery at The University of Texas MD Anderson Cancer Center, offered recommendations for clinical follow-up of patients with melanoma during a presentation at HemOnc Today Melanoma and Cutaneous Malignancies.

“It’s a very important part of our clinical practice,” Ross said. “I think it’s important to review what we do all of the time to see if we’re actually benefitting patients, particularly in the context of what is cost-effective. A lot of our surveillance maneuvers can be very expensive, particularly when we start doing routine imaging.”

Ross discussed how recurrence risk and timing vary according to disease stage, and suggested a better understanding of contemporary stage IV patients is necessary.